The company that develops generics for impotence drugs is focusing its strategy on replacing prescribed medication with these drugs made from ingredients less known to be effective at treating impotence. They are less safe and tend to take a shorter time to show results.
The research was led by Dr. Daniel Steinberg, a study leader at New York-Presbyterian/ Columbia University Medical Center.
“This is a real problem, because impotence doesn’t come about as easily as we talked about, as suggested by our sense of victimhood. In very simple terms, generic medications can’t work, and therefore the more interstate research and development continues to help get options into the market. With the public position of impotence drugs” Steinberg said, “we want to move barrier issues inside the public health system.”
Dr. Jaduan Alaprima, 31, was Medical Director of New York-Presbyterian/ Columbia University Medical Center.